Status:
COMPLETED
Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD)
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Neuroscouting, L.L.C.
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
8-11 years
Phase:
NA
Brief Summary
This study evaluates the impact of computerized inhibitory control training on attention-deficit hyperactivity disorder (ADHD) symptoms and ADHD-linked neural signatures in children with ADHD. Childre...
Detailed Description
Both medication and cognitive behavioral therapy are effective treatments for many children, however, adherence to both medication and therapy regimes is low. Thus, identifying effective adjunct treat...
Eligibility Criteria
Inclusion
- Diagnosis of inattentive or combined subtype ADHD by a licensed clinician and consistent acess to Wi-Fi at home.
Exclusion
- Any known genetic abnormalities, a diagnosis of autism spectrum disorder, or current use of medication for psychiatric disorders other than ADHD (e.g. depression, anxiety).
Key Trial Info
Start Date :
July 18 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2014
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03363568
Start Date
July 18 2013
End Date
March 3 2014
Last Update
December 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115